Respiratory Inhalers market is projected to grow at a CAGR of 8.02% by 2033: Visiongain Reports Ltd
15 déc. 2022 05h29 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Respiratory Inhalers 2023-2033. It includes profiles of Respiratory Inhalers and Forecasts Market Segment by Product Type (Standard Pressurized...
Ophthalmic drugs market is projected to grow at a CAGR of 6.39% by 2033: Visiongain Reports Ltd
13 déc. 2022 07h52 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled ophthalmic drugs 2023-2033. It includes profiles of Ophthalmic drugs and Forecasts Market Segment Type (Prescription Drugs, OTC Drugs), Market Segment by...
Alzheimer’s Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd
13 déc. 2022 06h46 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
The Stem Cell Technologies and Applications market is projected to grow at a CAGR of 8.9% by 2032: Visiongain Reports Ltd
06 déc. 2022 12h02 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and Applications and Forecasts Market Segment by Type,...
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
28 nov. 2022 12h08 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
25 nov. 2022 12h07 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
Dermatology Drugs market is projected to grow at a CAGR of 6.2% by 2032: Visiongain Reports Ltd
21 nov. 2022 11h32 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Dermatology Drugs 2022-2032. It includes profiles of Dermatology Drugs and Forecasts Market Segment by Disease (Psoriasis, Dermatitis, Acne, Skin...
Global Anti-Infective Vaccines Market is projected to grow at a CAGR of 12.51% by 2032: Visiongain Reports Ltd
16 nov. 2022 09h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Anti-Infective Vaccines Market 2022-2032 - which includes profiles of Anti-infective Vaccines and Forecasts Market Segment by Disease Type {Bacterial...
Global HIV and HBV Therapies market is projected to grow at a CAGR of 6.5% by 2032: Visiongain Reports Ltd
14 nov. 2022 07h21 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Global HIV and HBV Therapies Market. It includes Market Segment by Drug Class (Combination Therapies, Nucleoside and Non-nucleoside RTIs, Integrase...
Antisense Oligonucleotide Therapeutics market is projected to grow at a CAGR of 13.71% by 2032: Visiongain Reports Ltd
27 oct. 2022 11h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antisense Oligonucleotide Therapeutics 2022-2032. It includes profiles of Antisense Oligonucleotide Therapeutics and Forecasts Market Segment by...